Results
 Formal comparisons between the two treatment plans were carried using Wilcoxon signed-rank testing  All data were available for analysis except the V20 and V30Gy volumes due to a lack of variability.  Significant differences, even with the Bonferroni correction, were observed for the mean and maximum doses delivered, as well as for the V50Gy volumes.
 The V45Gy volumes also appeared different between the two treatment plans (Table 2 ) and would normally be considered significant at the P-value≤0.05 threshold, but because the threshold P-value was adjusted using the Bonferroni correction, it was no longer significant. Sparing VMAT V50Gy
